NON-SMALL CELL LUNG CANCERS
Clinical trials for NON-SMALL CELL LUNG CANCERS explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCERS trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental combo for rare Gene-Mutated cancers halted early
Disease control TerminatedThis study tested a new drug (PRT3789) combined with the immunotherapy pembrolizumab in people with advanced cancers that have a specific genetic change called SMARCA4. The goal was to see if the combination was safe and could shrink tumors. The study was terminated early after e…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:16 UTC
-
Cancer drug combo trial halted after just one patient
Disease control TerminatedThis early-stage trial aimed to test the safety and best dose of combining two drugs (adagrasib and olaparib) for people with advanced solid tumors that have a specific genetic change called KRAS G12C. The study focused on certain cancers like gynecological, breast, pancreatic, a…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 20, 2026 11:53 UTC